Fimasartan on Hypertensive Cardiac Disease With Left Ventricular Hypertrophy Estimated by ECG
NCT03219632 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 72
Last updated 2017-07-17
Summary
Assess the efficacy of fimasartan on left ventricular hypertrophy in hypertensive patients
Conditions
- Left Ventricular Hypertrophy
- Hypertension
Interventions
- DRUG
-
Fimasartan
Fimasartan is a non-peptide angiotensin II receptor antagonist (ARB) used for the treatment of hypertension and heart failure.
Sponsors & Collaborators
-
Seoul National University Bundang Hospital
lead OTHER
Principal Investigators
-
Dong-Ju choi · Seoul National University Bundang Hospital
Eligibility
- Min Age
- 20 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-06-05
- Primary Completion
- 2017-04-30
- Completion
- 2017-05-30
More Related Trials
-
A Clinical Study to Evaluate Efficacy and Safety of Fimasartan/Hydrochlorothiazide Combination-therapy
NCT01258673 ·Status: COMPLETED ·Phase: PHASE3
-
A Therapeutic Exploratory Clinical Study to Evaluate the Antihypertensive Efficacy of Fimasartan (BR-A-657•K) During 24 Hours in Patients With Mild to Moderate Essential Hypertension
NCT00922441 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Study to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan in Hypertension Patients
NCT00922480 ·Status: COMPLETED ·Phase: PHASE3
-
Antihypertensive Efficacy and Tolerability and Determine the Adequate Antihypertensive Dosage of Fimasartan in Mild to Moderate Essential Hypertension Patients
NCT00923611 ·Status: COMPLETED ·Phase: PHASE2
-
Candesartan Effectiveness Study in Pro-B Type Natriuretic Peptides (BNP)
NCT00348686 ·Status: COMPLETED ·Phase: PHASE4
-
A Clinical Trial to Evaluate the Effect of Fimarsartan on Pharmacodynamics, Pharmacokinetics, and the Safety of Warfarin in Healthy Male Volunteers
NCT00938132 ·Status: COMPLETED ·Phase: PHASE1
-
A Randomized, Double-blind, Active Control, Parallel Group, Titration, Multicenter Study to Evaluate the Efficacy and Safety of Fimasartan
NCT02620306 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Trial to Evaluate Efficacy, Tolerability, and Pharmacokinetic-Pharmacodynamic Relationship of Fimasartan/Hydrochlorothiazide
NCT02222480 ·Status: COMPLETED ·Phase: PHASE2
-
Fimasartan Achieving SBP Target (FAST) Study
NCT02495324 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of fimaSartan on arTerIal stiFFness iN patiEntS With HypertenSion
NCT02022774 ·Status: COMPLETED
-
A Multicenter, Phase 3 Study to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan(BR-A-657∙K) 30mg Compared to Placebo in Patients With Mild to Moderate Essential Hypertension
NCT01672476 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Angiotensin Converting Enzyme (ACE) Inhibitors Versus Candesartan in Reducing Cardiovascular Events in Primary Treatment of Hypertension
NCT01152567 ·Status: COMPLETED
-
Clinical Characteristics and Medication Satisfaction of Kanarb Tablet in Korean Hypertensive Patient(Kanarb-Hypertension Epidemiology Medication Satisfaction Study)
NCT02394392 ·Status: COMPLETED
-
Efficacy, Safety and Pharmacodynamic/Pharmacokinetic Study of Fimasartan (BR-A-657•K)
NCT00937651 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Antihypertensive Effect of Hyzaar(R) and Cognitive Function of Hypertensive Patients (0954A-322)
NCT00398541 ·Status: COMPLETED ·Phase: PHASE3
-
Reducing the Overall Risk Level in Patients Suffering From Metabolic Syndrome
NCT00821574 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Asian Patients With Essential Hypertension
NCT01785472 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Compare and Assess the Safety and Pharmacokinetic Characteristics After Oral Administration of Fimasartan (BR-A-657∙K) in Healthy Elderly and Young Male Volunteers
NCT00937534 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of Valsartan and Nebivolol/Valsartan in Hypertensive Patients With LVH
NCT03180593 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Elderly Patients With Essential Hypertension
NCT01615198 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Trial to Evaluate Pharmacokinetic Interactions and Safety Between Fimasartan and Linagliptin in Healthy Male Volunteers
NCT03250052 ·Status: COMPLETED ·Phase: PHASE1
-
Post-Authorization Long-term Safety Surveillance on Antihypertensive Treatment With Kanarb® (Fimasartan)
NCT02385721 ·Status: COMPLETED
-
Hypertension and Cardiovascular Risk Factors
NCT00171782 ·Status: COMPLETED ·Phase: PHASE4
-
A Clinical Trial to Compare and Evaluate the Pharmacokinetic Characteristics and the Safety of Fimasartan in Renal Impairment Patients and Healthy Volunteers
NCT01148368 ·Status: COMPLETED ·Phase: PHASE1
-
Valsartan for Attenuating Disease Evolution In Early Sarcomeric HCM
NCT01912534 ·Status: COMPLETED ·Phase: PHASE2